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Conventional hemodialysis (CHD) treatment is a basic renal replacement therapy (RRT) that
has been serving and supporting the life of patients with end-stage renal disease (ESRD) for
many years. The capabilities of this modality, which is based on the physiologic principle of
diffusion, are however limited. In reality, CHD can remove excess fluids but with some difficulty
in maintaining hemodynamic stability and can only clear small-size uremic toxins of less than
500 Da such as urea and creatinine but not larger-size uremic toxins of more than 500 Da. These
include middle molecules such as β2-microglobulin and protein-bound molecules such as
indoxyl sulfate and p-cresol, where their accumulation in the blood can lead to hemodialysis-
related amyloidosis and endothelial inflammation and toxicity, respectively. This may explain,
at least in part, the high incidence of morbidity and mortality in patients treated with CHD.
Furthermore, the intradialytic complications and post-dialysis tiredness, fatigue, and exhaus‐
tion have negatively influenced the quality of life of dialysis patients.
The recent technical advances in dialysis machine specifications, production of ultrapure water
by  modern  water  treatment  system,  innovation  of  synthetic  biocompatible  high-cut-off
membranes,  achievement  of  scientific  knowledge in  implementing the  other  physiologic
principle of convection, and combining diffusion with convection have all revolutionized the
dialysis  technique.  For example,  the modality of  hemofiltration (HF),  which is  based on
convection, is capable of removing larger-size molecules of more than 500 Da, whereas the
modality of hemodiafiltration (HDF), which combines diffusion and convection, is capable of
removing small- and larger-size uremic toxins. In addition, both of these techniques provide
more hemodynamic stability, which is more evident with online HDF. Over many years, multiple
observational and randomized clinical trials showed plenty of clinical benefits of online HDF,
which had significant impact on morbidity and mortality rates. Since the establishment and
implementation of online HDF, a significant experience and knowledge have been gained in
ways of its application and achievement of beneficial clinical results (Figure 1).
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Figure 1. Major milestones in the development of online HDF.
The Advances in Hemodiafiltration book has been specifically designed to describe and demon‐
strate the treatment modality of HDF from its basic concepts to the most recent advances in
the techniques of its implementation. Under specific titles of specially created chapters, this
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book covers principles of HDF, generation of ultrapure water, fluid convection and reinfusion,
factors affecting convective dose, dialysis machine-dependent technical factors, prescription
of HDF, performance and effectiveness of HDF, clinical benefits including results of major
randomized clinical trials, effects of online HDF on arterial stiffness and heart failure, quality
of life of patients on HDF, cost-effectiveness of HDF, and applicability of HDF at home.
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